Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
73.33 USD | +4.34% | +10.79% | -0.58% |
May. 17 | Nuvalent Insider Sold Shares Worth $345,450, According to a Recent SEC Filing | MT |
May. 16 | Nuvalent Gets FDA Breakthrough Therapy Designation for Lung-Cancer Treatment | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.58% | 4.54B | |
+55.64% | 55.7B | |
+41.08% | 39.91B | |
-5.67% | 39.57B | |
-5.56% | 28.16B | |
+16.14% | 26.3B | |
-20.60% | 18.94B | |
+32.91% | 12.17B | |
+26.01% | 12.12B | |
+2.60% | 12.12B |
- Stock Market
- Equities
- NUVL Stock
- News Nuvalent, Inc.
- Wedbush Raises Nuvalent's Price Target to $99 From $82, Maintains Outperform Rating